Tele: 561.316.3330
Breaking Medical Device News

Thursday, October 21, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeSTEMCELL TechnologiesSTEMCELL Technologies to Launch CloneR™ to Facilitate Genome Editing of Human Pluripotent...

STEMCELL Technologies to Launch CloneR™ to Facilitate Genome Editing of Human Pluripotent Stem Cells

STEMCELL Technologies announces the development of CloneR™, a novel medium formulation to aid researchers in their ability to successfully genome edit human pluripotent stem cells. This supplement represents a dramatic improvement over existing technologies.

Editing the pluripotent stem cell genome relies heavily on the survival of single cells to establish clonal cell lines. CloneR™ is a medium supplement designed for greatly enhancing the cloning efficiency and single-cell survival of pluripotent stem cells. Unlike current methods, CloneR™ will enable the robust generation of clonal cell lines without single-cell adaptation, thus minimizing the risk of acquiring genetic abnormalities. Such irregularities bear a close resemblance to those found in many human cancers, raising safety concerns for the use of these cells in regenerative medicine.

“As the market-leader for the development of innovative products for pluripotent stem cell research, we are delighted to announce the imminent launch of CloneR™,” says Dr. Allen Eaves, CEO and President of STEMCELL Technologies. “We are confident that this new invention will enable researchers by improving their capacity for disease modeling, drug screening and the development of cell and gene therapies for regenerative medicine.”

CloneR™ will build upon STEMCELL’s extensive portfolio of products to support pluripotent stem cell research, including mTeSR™1, the most widely published feeder-free maintenance medium on the market. The CloneR™ supplement will be manufactured using STEMCELL’s rigorous raw material screening and quality control processes certified under ISO 13485, Medical Devices Standards. This will ensure that the final product is of the highest quality, with maximal performance and minimal lot-to-lot variability.

To receive a notification of the product launch, sign up here: www.stemcell.com/CloneR

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Contraline Closes $10.7 Million Series A Financing to Become a Clinical Stage Company

This infusion of capital will support the initiation of a first-in-human trial of ADAM™, the world’s first hydrogel implant designed to provide long-lasting, non-permanent contraception for men.

Adam S. Epstein New CEO of AliMed, Inc.

In his prior role as Chief Commercial Officer, Epstein directed all customer-facing, demand generation and product development activities. Under his new leadership, AliMed will continue to build a robust portfolio of contracted positions with major, national GPO’s, IDN’s, and Distribution partners to drive sales growth.

Tony Collins Appointed CFO of Xenter

“Xenter is building a platform for medical innovations that is transformational. The only way we can achieve our objectives is if we have great leaders like Tony Collins leading our company,” stated Richard J. Linder, Founder, Chairman & CEO of Xenter, Inc. “Tony brings incredible depth and experience to his new role as Chief Financial Officer.

Scott Sexton Appointed President at FIGUR8

"Scott brings to FIGUR8 30 years of workers' compensation, casualty, disability, and commercial health experience, most recently serving as a market leader for CorVel's national carrier practice sales team," said Nan-Wei Gong, CEO, and co-founder of FIGUR8.

Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford

Luciana Borio MD is a respected physician with vast experience in advancing major regulatory and policy agendas for the United States.

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

By using this website you agree to accept Medical Device News Magazine Privacy Policy